Home › Intervertebral Disc Degeneration › NCT06226272

Clinical Outcome Measure at Stryker Spine

Clinical Outcome Measure at Stryker Spine: COMPASS

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

• To be eligible to participate in the study, the potential subject must meet all inclusion criteria specific to the Stryker system being evaluated, please contact one of the participating investigators or see the device-specific cleared IFU, for further details.

Exclusion Criteria:

• The exclusion criteria are based on the contraindications as presented in the Stryker device cleared IFUs, please contact one of the participating investigators or see the device-specific cleared IFU, for further details.

About the study

This is a multicenter, prospective, retrospective, Post Market Clinical Follow-up (PMCF) study in subjects who have undergone or will undergo surgery utilizing one or more Stryker devices according to Stryker cleared Instructions for Use (IFU).

What is being tested

• Spinal Fusion (device)
• Spinal Fusion (device)
• Spinal Deformities Correction (device)

Sponsor: VB Spine, LLC · Participants: 5,222 · Started: Jan 28, 2025

Contact the study team

• Mary Majer · Phone: 866-526-4171
• Effa Gyamfi · Phone: 866-526-4171

Official record on ClinicalTrials.gov — NCT06226272

Locations in the U.S.

Conditions

• Intervertebral Disc Degeneration

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.